Cited by 218Endometrial and Cervical Cancer TreatmentsPI3K/AKT/mTOR signaling in cancerCervical Cancer and HPV Research

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

PIK3CA and PTEN Mutations in Uterine Endometrioid Carcinoma and Complex Atypical Hyperplasia

Hayes, Monica Prasad, Wang, Hong, Espinal-Witter, Rosanny, Douglas, Wayne, Solomon, Garron J., Baker, Suzanne J., Ellenson, Lora Hedrick·2006·Clinical Cancer Research

DOI 10.1158/1078-0432.ccr-06-1375

Open this paper in CoChat — free account

Abstract

Purpose: The tumor suppressor PTEN gene and the PIK3CA oncogene are frequently mutated in uterine endometrioid carcinoma (UEC). PTEN mutations are also common in complex atypical hyperplasia (CAH), the precursor lesion of UEC. The status of PIK3CA has not yet been explored in CAH. In this study, we evaluated both CAH and UEC for PTEN and PIK3CA mutations. Experimental Design: Neoplastic tissue was microdissected, and DNA was extracted from 29 cases of CAH. DNA was available from 44 UEC cases previously characterized for PTEN mutations. Direct DNA sequencing of exons 9 and 20 of the PIK3CA gene was done on all 73 cases. In addition, CAH cases were analyzed for PTEN mutations. Statistical analyses were done using the Fisher's exact test. Results: Two (7%) of 29 CAH and 17 (39%) of 44 UEC cases contained a PIK3CA mutation (P = 0.003). Fourteen (48%) of 29 CAH cases had a PTEN mutation, but none contained both a PTEN and PIK3CA mutation. Twenty-five (57%) of 44 UEC cases had a PTEN mutation, and 12 (48%) of these 25 cases also contained a PIK3CA mutation. Coexistent PIK3CA and PTEN mutations were significantly correlated with UEC compared with CAH (P = 0.002), but the association in UEC did not reach statistical significance (P = 0.21). Conclusions: PIK3CA is the most commonly mutated oncogene in UEC; however, mutations are uncommon in CAH. Thus, mutations in PIK3CA, unlike PTEN mutations, are associated with invasion. These findings suggest that mutations in PIK3CA may serve as a marker of invasion with potential clinical use. Furthermore, PIK3CA and PTEN mutations may play distinct roles in endometrial tumorigenesis.

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-06-1375

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Cancer Statistics, 2006
Jemal, A., Siegel, R. L., Ward, E. M., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,309
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R. A., Godfrey, T. E., Collins, C. C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,158
Mutation of the PIK3CA Gene in Ovarian and Breast Cancer
Campbell, I., Russell, S. E., Choong, D. Y. H., Montgomery, K. G., Ciavarella, M. L., Hooi, C. S. F., Cristiano, B. E., Pearson, R. B., & Phillips, W. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2933 · Cited by 917
Mutant PIK3CA promotes cell growth and invasion of human cancer cells.
Samuels, Y., Diaz, L. A., Schmidt-Kittler, O., Cummins, J. M., DeLong, L., Cheong, I., Rago, C., Huso, D. L., Lengauer, C., Kinzler, K. W., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.014 · Cited by 915
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
Kang, S., Bader, A. G., & Vogt, P. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408864102 · Cited by 827
Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R. E., & Ellenson, L. H. (1997) · PubMed · Cited by 701
Self-citation
Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia
Trimble, C. L., Kauderer, J. T., Zaino, R. J., Silverberg, S., Lim, P., Burke, J. J., Alberts, D. S., & Curtin, J. P. (2006) · Cancer · doi:10.1002/cncr.21650 · Cited by 603
Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells
Isakoff, S. J., Engelman, J. A., Irie, H. Y., Luo, J., Brachmann, S. M., Pearline, R. V., Cantley, L. C., & Brugge, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2612 · Cited by 505

Show all 23 references

Sorted by citations

Items 101–200 of 218

PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer
Mjøs, S., Werner, H. M., Birkeland, E., Holst, F., Berg, A., Halle, M. K., Tangen, I., Kusonmano, K., Mauland, K., Oyan, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10717-z · Cited by 27
Recent Developments in Surgical Pathology of the Uterine Corpus
Hanley, K. Z., Birdsong, G. G., & Mošunjac, M. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0284-sa · Cited by 34
Type II endometrial cancer: Incidence, overall and disease-free survival in Martinique
Ebring, C., Marlin, R., Macni, J., Vallard, A., Bergerac, S., Beaubrun‐Renard, M., Joachim, C., & Jean-Laurent, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0278757 · Cited by 33
Concomitant activation of AKT with extracellular‐regulated kinase 1/2 occurs independently of PTEN or PIK3CA mutations in endometrial cancer and may be associated with favorable prognosiss
Mori, N., Kyo, S., Sakaguchi, J., Mizumoto, Y., Ohno, S., Maida, Y., Hashimoto, M., Takakura, M., & Inoue, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00630.x · Cited by 34
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first–line treatment of metastatic colorectal cancer
Gilcrease, G. W., Stenehjem, D. D., Wade, M. L., Weis, J. R., McGregor, K., Whisenant, J. R., Boucher, K. M., Thorne, K., Orgain, N., Garrido‐Laguna, I., et al. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0645-2 · Cited by 33
Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma
Sugiyama, Y., Gotoh, O., Fukui, N., Tanaka, N., Hasumi, K., Takazawa, Y., Noda, T., & Mori, S. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.09.022 · Cited by 33
Activation of NF-κB Is a Novel Target of KRAS-Induced Endometrial Carcinogenesis
Mizumoto, Y., Kyo, S., Kiyono, T., Takakura, M., Nakamura, M., Maida, Y., Mori, N., Bono, Y., Sakurai, H., & Inoue, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2291 · Cited by 32
Molecular genetics of endometrial carcinoma
Catasús, L., Gallardo, A., & Prat, J. (2009) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2009.09.002 · Cited by 30
The role and participation of immune cells in the endometrial tumor microenvironment
Dey, D. K., Krause, D., Rai, R., Choudhary, S., Dockery, L., & Chandra, V. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108526 · Cited by 29
Molecular Alterations of PIK3CA in Uterine Carcinosarcoma, Clear Cell, and Serous Tumors
Bashir, S., Jiang, G., Joshi, A. R., Miller, C. A., Matrai, C. E., Yemelyanova, A. V., Caputo, T. A., Holcomb, K., Ellenson, L. H., & Gupta, D. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000183 · Cited by 29
Self-citation
Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study
Lacey, J. V., Yang, H., Gaudet, M. M., Dunning, A. M., Lissowska, J., Sherman, M. E., Pepłońska, B., Brinton, L. A., Healey, C. S., Ahmed, S., et al. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.10.016 · Cited by 28
A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding
Painter, J. N., Kaufmann, S., O’Mara, T. A., Hillman, K. M., Sivakumaran, H., Darabi, H., Cheng, T. H. T., Pearson, J. V., Kazakoff, S. H., Waddell, N., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.04.012 · Cited by 28
Integrative Analysis of Differently Expressed Genes Reveals a 17‐Gene Prognosis Signature for Endometrial Carcinoma
Wang, A., Guo, H., & Long, Z. (2021) · BioMed Research International · doi:10.1155/2021/4804694 · Cited by 27
Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma
Gao, Q., Ye, F., Xia, X., Xing, H., Lu, Y., Zhou, J., & Ma, D. (2009) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-009-0112-6 · Cited by 27
Activated Mutant p110α Causes Endometrial Carcinoma in the Setting of Biallelic Pten Deletion
Joshi, A. R., Miller, C. A., Baker, S. J., & Ellenson, L. H. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.12.019 · Cited by 28
Self-citation
Anatomopathologie des cancers de l’endomètre
Albertini, A.-F., Devouassoux‐Shisheboran, M., & Genestie, C. (2012) · Bulletin du Cancer · doi:10.1684/bdc.2011.1526 · Cited by 27
N-cadherin expression level as a critical indicator of invasion in non-epithelial tumors
Péglion, F., & Etienne‐Manneville, S. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20855 · Cited by 29
Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer
de Andrade, D. A. P., da Silva, V. D., Matsushita, G. D. M., de Lima, M. A., Vieira, M. D. A., Andrade, C. E. M. C., Schmidt, R. L., Reis, R. M., & dos Reis, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220086 · Cited by 26
Endometrial Tumorigenesis in Pten Mice Is Independent of Coexistence of Estrogen and Estrogen Receptor α
Joshi, A. R., Wang, H., Jiang, G., Douglas, W., Chan, J. S. Y., Korach, K. S., & Ellenson, L. H. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.03.006 · Cited by 26
Self-citation
Emerging strategies for targeting PI3K in gynecologic cancer
Bregar, A. J., & Growdon, W. B. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.09.083 · Cited by 25
Loss of Inhibitory Insulin Receptor Substrate-1 Phosphorylation Is an Early Event in Mammalian Target of Rapamycin–Dependent Endometrial Hyperplasia and Carcinoma
McCampbell, A. S., Harris, H. A., Crabtree, J. S., Winneker, R. C., Walker, C. L., & Broaddus, R. R. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0199 · Cited by 25
The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2
Chao, A., Lin, C., Wu, R., Lee, Y., Lee, L., Tsai, C.-L., Yang, L., Liu, H., Chen, S., Wang, T., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1699-5 · Cited by 25
Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer
Malentacchi, F., Turrini, I., Sorbi, F., Projetto, E., Castiglione, F., Fambrini, M., Petraglia, F., Pillozzi, S., & Noci, I. (2018) · Oncology Reports · doi:10.3892/or.2018.6939 · Cited by 23
Outcomes of fertility preservation treatments in patients with endometrial cancer with different molecular classifications based on an NGS panel
Xu, Y., Zhao, M., Zhang, L., Wang, T., Wang, B., Xue, Y., Xu, Z., Shao, W., Chen, X., & Wang, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1282356 · Cited by 22
PIK3CA/AKT1 Mutations in Breast Carcinoma: a Comprehensive Review of Experimental and Clinical Studies
Troxell, M. L. (2012) · Journal of Clinical & Experimental Pathology · doi:10.4172/2161-0681.s1-002 · Cited by 24
Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma
de la Vega, L. L., Samaha, M. C., Hu, K. M., Bick, N. R., Siddiqui, J., Hovelson, D. H., Liu, C., Carter, C. S., Cho, K. R., Sciallis, A. P., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1178 · Cited by 22
PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis
Bredin, H. K., Krakstad, C., & Høivik, E. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283203 · Cited by 24
Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer
Mori, N., Kyo, S., Nakamura, M., Hashimoto, M., Maida, Y., Mizumoto, Y., Takakura, M., Ohno, S., Kiyono, T., & Inoue, M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605805 · Cited by 21
High-sensitive colorimetric biosensing of PIK3CA gene mutation based on mismatched ligation-triggered cascade strand displacement amplification
Shen, C., Shen, B., Mo, F., Zhou, X., Duan, X., Wei, X., Li, J., Duan, Y., Cheng, W., & Ding, S. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.06.041 · Cited by 20
Genomic Characterization of Gene Copy-Number Aberrations in Endometrial Carcinoma Cell Lines Derived from Endometrioid-Type Endometrial Adenocarcinoma
Wang, Y., Yang, D., Cogdell, D. E., Hu, L., Xue, F., Broaddus, R. R., & Zhang, W. (2010) · Technology in Cancer Research & Treatment · doi:10.1177/153303461000900207 · Cited by 20
Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma
Gotoh, O., Sugiyama, Y., Tonooka, A., Kosugi, M., Kitaura, S., Minegishi, R., Sano, M., Amino, S., Furuya, R., Tanaka, N., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6278 · Cited by 19
Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium
Geels, Y. P., van der Putten, L. J. M., van Tilborg, A. A. G., Lurkin, I., Zwarthoff, E. C., Pijnenborg, J. M. A., Erp, S. V. D. B.-V., Snijders, M. P. L. M., Bulten, J., Visscher, D. W., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.03.007 · Cited by 19
Immunohistochemical characterization of endometrial carcinomas: Endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis
Yasuda, M. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12564 · Cited by 18
Classification histologique et moléculaire des cancers de l’endomètre et leurs implications dans la thérapeutique
Genestie, C., Leary, A. F., Devouassoux‐Shisheboran, M., & Auguste, A. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.08.004 · Cited by 18
Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes
Stemke‐Hale, K., Shipman, K. L., Kitsou-Mylona, I., de Castro, D. G., Hird, V., Brown, R. E., Flanagan, J. M., Gabra, H., Mills, G. B., Agarwal, R., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.194 · Cited by 18
New Routes to Old Places: PIK3R1 and PIK3R2 Join PIK3CA and PTEN as Endometrial Cancer Genes
Herrero‐González, S., & Cristofano, A. D. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0116 · Cited by 18
Evaluation of Expression of the PTEN Gene, Oestrogen and Progesterone Receptors as Diagnostic and Predictive Factors in Endometrial Cancer
Samulak, D., Grosman-Dziewiszek, P., Michalska, M., Mojs, E. H., Samulak, K., Romanowicz, H., & Smolarz, B. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9684-3 · Cited by 17
Prognostic Significance of Mucinous Differentiation of Endometrioid Adenocarcinoma of the Endometrium
Galic, V., Schiavone, M. B., Herzog, T. J., Holcomb, K., Lewin, S. N., Lu, Y., Neugut, A. I., Hershman, D. L., & Wright, J. D. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.820321 · Cited by 17
Molecular characterization of endometrial cancer and therapeutic implications
Uppendahl, L. D., Mullany, S. A., & Winterhoff, B. J. N. (2016) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000342 · Cited by 16
PI3K/PTEN/AKT Genetic Mouse Models of Endometrial Carcinoma
Joshi, A. R., & Ellenson, L. H. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43139-0_9 · Cited by 16
Self-citation
Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation
Karlsson, T., Krakstad, C., Tangen, I. L., Høivik, E. A., Pollock, P. M., Salvesen, H. B., & Lewis, A. E. (2016) · Oncotarget · doi:10.18632/oncotarget.13989 · Cited by 16
Familial clustering of endometrial cancer in a well-defined population
Seger, H. M. M., Soisson, A. P., Dodson, M. K., Rowe, K. G., & Cannon‐Albright, L. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.03.009 · Cited by 15
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
Rodríguez-Freixinós, V., Ruíz‐Pace, F., Fariñas-Madrid, L., Garrido-Castro, A. C., Villacampa, G. J., Nuciforo, P. G., Vivancos, A. P., Dienstmann, R., & Oaknin, A. (2019) · ESMO Open · doi:10.1136/esmoopen-2018-000444 · Cited by 14
New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?
Rodríguez-Freixinós, V., Karakasis, K., & Oza, A. M. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0507-z · Cited by 14
Rare Mutations in the PIK3CA Gene Contribute to Aggressive Endometrial Cancer
Konstantinova, D. V., Kaneva, R. P., Dimitrov, R., Savov, A. S., Ivanov, S., Dyankova, T., Kremensky, I. M., & Mitev, V. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0939 · Cited by 14
Molecular changes in the phosphatidylinositide 3‐kinase (PI3K) pathway are common in gastric cancer
Tran, T. N., Brettingham‐Moore, K. H., Duong, C. P., Mitchell, C., Clemons, N. J., & Phillips, W. A. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23357 · Cited by 13
PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3′-kinase pathway alterations might be associated with favorable prognosis
Dong, Y., Yang, X., Wong, O. G., Zhang, X., Liang, Y., Zhang, Y., Wong, W., Nong, L., Liao, Q., & Li, T. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.08.021 · Cited by 13
Endometrial Carcinoma
Ellenson, L. H., Ronnett, B. M., Soslow, R. A., Lastra, R. R., & Kurman, R. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6_9 · Cited by 13
Self-citation
Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function
Blanco, B., Herrero-Sánchez, C., Rodríguez‐Serrano, C., Sánchez‐Barba, M., & del Cañizo, M. C. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.032 · Cited by 12
Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer
Djordjevic, B., Westin, S. N., & Broaddus, R. R. (2012) · Surgical pathology clinics · doi:10.1016/j.path.2012.08.004 · Cited by 12
Genomic insights in gynecologic cancer
Roddy, E., & Chapman, J. (2016) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2016.11.001 · Cited by 12
Clinicopathological and molecular characteristics of endometrial neuroendocrine carcinomas reveal preexisting endometrial carcinoma origin
Ono, K., Kasajima, R., Katayama, K., Miyagi, Y., & Yokose, T. (2021) · Pathology International · doi:10.1111/pin.13108 · Cited by 11
Targeted Endometrial Cancer Therapy as a Future Prospect
Thanapprapasr, D., Cheewakriangkrai, C., Likittanasombut, P., Thanapprapasr, K., & Mutch, D. G. (2013) · Women s Health · doi:10.2217/whe.13.4 · Cited by 11
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma
Koivisto, C. S., Parrish, M., Bonala, S., Ngoi, S. M., Torres, A., Gallagher, J., Sanchez‐Hodge, R., Zeinner, V., Nahhas, G. J., Liu, B., et al. (2020) · Neoplasia · doi:10.1016/j.neo.2020.07.003 · Cited by 11
Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study
Zhang, G., Nie, F., Zhao, W.-N., Pin, H., Wen, J., Cheng, X., Wu, W., Liu, Q., Sun, Y., Wang, Y., et al. (2023) · World Journal of Surgical Oncology · doi:10.1186/s12957-023-03241-0 · Cited by 10
Nuclear upregulation of class I phosphoinositide 3-kinase p110β correlates with high 47S rRNA levels in cancer cells
Gavgani, F. M., Karlsson, T., Tangen, I. L., Morovicz, A. P., Arnesen, V. S., Turcu, D. C., Ninzima, S., Spang, K., Krakstad, C., Guillermet‐Guibert, J., et al. (2021) · Journal of Cell Science · doi:10.1242/jcs.246090 · Cited by 11
Expression of PTEN in Endometrial Liquid-Based Cytology
Lorito, A. D., Zappacosta, R., Capanna, S., Gatta, D. M. P., Rosini, S., & Schmitt, F. C. (2014) · Acta Cytologica · doi:10.1159/000367961 · Cited by 10
Unresolved issues in the management of endometrial cancer
Holland, C. M. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.207 · Cited by 10
Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer
Yeramian, A., García, V., Bergadà, L., Domingo, M., Santacana, M., Valls, J., Martínez‐Alonso, M., Carceller, J.-A., Llombart‐Cussac, A., Dolcet, X., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0907-8 · Cited by 10
The Role of Hepsin in Endometrial Carcinoma
El-Rebey, H. S., Kandil, M. A., Samaka, R. M., Al‐Sharaky, D. R., & Deeb, K. E. (2016) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000352 · Cited by 9
Molecular alterations in endometrial archived liquid‐based cytology
Lorito, A. D., Rosini, S., Falò, E., Gustapane, S., Gomes, M., Costa, J. L., & Schmitt, F. C. (2012) · Diagnostic Cytopathology · doi:10.1002/dc.22869 · Cited by 9
Protein Kinase CαModulates Estrogen-Receptor-Dependent Transcription and Proliferation in Endometrial Cancer Cells
Thorne, A. M., Jackson, T. A., Willis, V. C., & Bradford, A. P. (2013) · Obstetrics and Gynecology International · doi:10.1155/2013/537479 · Cited by 8
Emerging relationships between papillary proliferation of the endometrium and endometrial carcinoma: evidence from an immunohistochemical and molecular analysis
Liu, Q., Wu, Q., Yu, M., Shi, H., & Lü, B. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02589-7 · Cited by 8
Diagnostic value of endometrial cytology and related technology
Munakata, S. (2022) · Diagnostic Cytopathology · doi:10.1002/dc.24956 · Cited by 7
Precursors of Endometrial Carcinoma
Ellenson, L. H., Ronnett, B. M., & Kurman, R. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6_8 · Cited by 7
Self-citation
Oviduct‐specific glycoprotein is a molecular marker for invasion in endometrial tumorigenesis identified using a relevant mouse model
Wang, H., Joshi, A. R., Iaconis, L., Solomon, G. J., Xiang, Z., Verhage, H. G., Douglas, W., Ronnett, B. M., & Ellenson, L. H. (2008) · International Journal of Cancer · doi:10.1002/ijc.24022 · Cited by 7
Self-citation
Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomas
Duchatel, R. J., Savary, C., Germon, Z. P., Riley, M., Ziegler, D. S., Mueller, S., Jackson, E. R., & Dun, M. D. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf163 · Cited by 7
The Application of Liquid Biopsy for the Development and Validation of a Non-Invasive Screening and Diagnosis Test for Endometrial Premalignant and Malignant Lesions: A Prospective Innovative Pilot Study
Esposito, G., D’Angelo, G., Falco, L. D., Evangelista, E., Savarese, G., Fico, A., Cinque, F., Giampaolino, P., Sardo, A. D. S., Bifulco, G., et al. (2025) · Cancers · doi:10.3390/cancers17071078 · Cited by 5
Le PAIR-gynécologie : recherche multi/interdisciplinaire en cancérologie gynécologique. Les problèmes à résoudre en 2012
Ray-Coquard, I. L., Chauvin, F., Leblanc, É., Caux, C., Hoarau, H., Bonnetain, F., Christophe, V., Sastre‐Garau, X., Lazennec, G., Poulain, L., et al. (2012) · Bulletin du Cancer · doi:10.1684/bdc.2012.1558 · Cited by 5
THE ROLE OF PHOSPHATIDYLINOSITOL-3-KINASE IN CARCINOGENESIS
Oskina, N., Shcherbakov, A., Filipenko, M., Kushlinskiy, N., & Овчинникова, Л. П. (2017) · Voprosy Onkologii · doi:10.37469/0507-3758-2017-63-4-545-556 · Cited by 4
Upregulation of PKN1 as a Prognosis Biomarker for Endometrial Cancer
Govorov, I., Attarha, S., Kovalevska, L. M., Andersson, E., Kashuba, E., & Mints, M. (2022) · Cancer Control · doi:10.1177/10732748221094797 · Cited by 4
Endometrial carcinoma: association between mutational status, sites of metastasis, recurrence, and correlation with overall survival
Luna, C., Goncalves, N., Metalonis, S. W., Mason, M. M., Lyu, J., Huang, M. S., & Alessandrino, F. (2023) · Abdominal Radiology · doi:10.1007/s00261-023-03973-3 · Cited by 4
Abnormal Expression of PICT-1 and Its Codon 389 Polymorphism Is a Risk Factor for Human Endometrial Cancer
Yoshimoto, M., Tokuda, A., 西脇, 邦., Sengoku, K., & Yaginuma, Y. (2018) · Oncology · doi:10.1159/000487189 · Cited by 4
Evolutionary pathways in early-stage, non-myoinvasive endometrioid endometrial cancers of no specific molecular profile
Moufarrij, S., Lakhman, Y., Aghajanian, C. A., Abu‐Rustum, N. R., Ellenson, L. H., Weigelt, B., & Boroujeni, A. M. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.10.029 · Cited by 3
Self-citation
mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells
Bülbül, M. V., Mermer, A., Kolbaşı, B., Kocabaş, F., Kalender, S. M., Aydın, A. K., Demircan, T., & Keskin, İ. (2024) · Pharmaceuticals · doi:10.3390/ph17121562 · Cited by 3
Precursors of Endometrial Carcinoma
Ellenson, L. H., Ronnett, B. M., & Kurman, R. J. (2018) · Springer eBooks · doi:10.1007/978-1-4614-3165-7_8-2 · Cited by 3
Self-citation
Molecular Detection and Diagnosis of Cancer
Patriotis, C., Maruvada, P., & Srivastava, S. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_41 · Cited by 3
Genetics of Endometrial Carcinoma
López-García, M. Á., Vieites, B., Castilla, M. Á., Romero‐Pérez, L., Díaz‐Martín, J., Biscuola, M., & Palacios, J. (2012) · Springer eBooks · doi:10.1007/978-94-007-5842-1_11 · Cited by 3
Molecular Pathogenesis of Uterine Serous Carcinoma
Nagase, S., Suzuki, F., Tokunaga, H., Toyoshima, M., Utsunomiya, H., Niikura, H., & Yaegashi, N. (2013) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-013-0069-0 · Cited by 2
Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma
Kosmas, K., Mitropoulou, G., Provatas, I., Stamoulas, M., & Marouga, A. (2018) · Cytopathology · doi:10.1111/cyt.12612 · Cited by 2
Phosphoinositide 3-kinase alterations in the thyroid gland – a review study
Wojciechowska-Durczyńska, K., & Lewiñski, A. (2009) · Archives of Medical Science · Cited by 2
Molecular Basis of Gynecologic Diseases
Mok, S. C., Wong, K., Lu, K. H., Münger, K., & Nagymányoki, Z. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00023-8 · Cited by 2
Endometrial hyperplasia versus carcinoma
Kholy, M. A. E., & Kholy, E. A. E. (2018) · The Scientific Journal of Al-Azhar Medical Faculty Girls · doi:10.4103/sjamf.sjamf_28_18 · Cited by 2
Application of immunocytochemical and molecular analysis of six genes in liquid‐based endometrial cytology
Munakata, S., & Yamamoto, T. (2021) · Diagnostic Cytopathology · doi:10.1002/dc.24903 · Cited by 2
Targeted Therapy and Prevention of Endometrial Cancer
Shiozaki, T., & Westin, S. N. (2017) · Molecular pathology library · doi:10.1007/978-3-319-57985-6_10 · Cited by 1
A systematic review and meta-analysis of the effects of green tea extracts and polyphenols in female hormone-dependent cancers for benefit-risk evaluation
He, J., Zhang, Y., He, Z.-H., & Zheng, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1579470 · Cited by 1
Molecular Pathology of Endometrioid Adenocarcinoma
Kurnit, K. C., Djordjevic, B., & Broaddus, R. R. (2017) · Molecular pathology library · doi:10.1007/978-3-319-57985-6_4 · Cited by 1
Molecular Basis of Gynecologic Diseases
Mok, S. C., Wong, K., Lu, K. H., Münger, K., & Nagymányoki, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00023-7 · Cited by 1
Therapeutic Options for Management of Endometrial Hyperplasia: An Update
Chandra, V., Kim, J.-J., Benbrook, D. M., Dwivedi, A., & Rai, R. (2015) · Cited by 1
Selected Topics in the Molecular Pathology of Endometrial Carcinoma
Djordjevic, B., & Broaddus, R. R. (2011) · Surgical pathology clinics · doi:10.1016/j.path.2010.12.001 · Cited by 1
Label propagation defines signaling networks associated with recurrently mutated cancer genes
Çakır, M., Mukherjee, S., & Wood, K. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-45603-3 · Cited by 1
Nouvelles perspectives et biomarqueurs dans le diagnostic et la prise en charge des tumeurs gynécologiques
Devouassoux‐Shisheboran, M., & Croce, S. (2012) · ONCOLOGIE · doi:10.1007/s10269-012-2204-3 · Cited by 1
Regulated expression of aggrecanases of ADAMTS family in endometrial physiology and pathology
Wen, J. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071568 · Cited by 1
Molecular Gynecologic Pathology
Hayes, M. P., Pirog, E. C., & Ellenson, L. H. (2009) · Elsevier eBooks · doi:10.1016/b978-044306901-7.50034-1 · Cited by 1
Self-citation
Precursors of Endometrial Carcinoma
Murdock, T. A., Veras, E. F. T., Kurman, R. J., & Mazur, M. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-98608-1_9 · Cited by 1
Beyond Base Camp: Promise and Pitfalls of PI3K/mTOR Inhibition in Pediatric High- Grade GliomasPreprint
Duchatel, R. J., Savary, C., Germon, Z. P., Riley, M., Ziegler, D. S., Mueller, S., Jackson, E. R., & Dun, M. D. (2025) · Research Square · doi:10.21203/rs.3.rs-6508597/v1 · Cited by 1
Molecular classification of familial colorectal and endometrial carcinoma
Ollikainen, M. (2007) · Työväentutkimus Vuosikirja
Prognosefaktoren gynäkologischer Malignome
van Mackelenbergh, M., & Mundhenke, C. (2015) · Der Gynäkologe · doi:10.1007/s00129-015-3795-8
PRELIMINARY STUDY ON THE OCCURRENCE OF PTEN AND PIK3CA GENE MUTATIONS IN ENDOMETRIAL CANCER AMONG MALAYSIAN WOMEN
Chung, I., Subramaniam, K. S., Ms, W., Woo, Y. L., Mat Adenan, N. A., & Mohamed, Z. (2013) · Journal of Health and Translational Medicine · doi:10.22452/jummec.vol16no1.3
Cancer de l’endomètre : actualités
Genestie, C., & Devouassoux‐Shisheboran, M. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)71889-6

Authors: Hayes, M. P., Wang, H., Espinal-Witter, R., Douglas, W., Solomon, G. J., Baker, S. J., & Ellenson, L. H.
Affiliations: Cornell University (US)
St. Jude Children's Research Hospital (US)
ORCID: Wang, Hong
Baker, Suzanne J.
Ellenson, Lora Hedrick
Venue: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2006-10-15
Volume: 12
Issue: 20
Pages: 5932-5935
ISSN: 1078-0432 (ISSN-L)
1557-3265
DOI: 10.1158/1078-0432.ccr-06-1375
OpenAlex: W2101549875
Cited by: 218
References: 23
Citations by year: 2025: 6 · 2024: 10 · 2023: 9 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 19 · 2018: 16 · 2017: 11 · 2016: 15 · 2015: 12 · 2014: 11 · 2013: 17 · 2012: 21
FWCI: 13.15
Type: journal article
Language: en
Open access: closed
Locations: Clinical Cancer Research (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA095427, CA 095427)
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords: PIK3CA mutation, PTEN mutation, endometrioid endometrial cancer, complex atypical hyperplasia, endometrial tumorigenesis, tumor invasion, co-occurring mutations, precursor lesions
MeSH terms: DNA, Neoplasm, Endometrium, Female, Humans, Hyperplasia, Mutation, Uterine Neoplasms, Endometrial Neoplasms, Phosphatidylinositol 3-Kinases, PTEN Phosphohydrolase, Class I Phosphatidylinositol 3-Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PIK3CA and PTEN Mutations in Uterine Endometrioid Carcinoma and Complex Atypical Hyperplasia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks